Heparin induced thrombocytopenia: diagnosis and management update
AUTOR(ES)
Ahmed, I
FONTE
BMJ Group
RESUMO
Heparin‐induced thrombocytopenia (HIT) is a potentially devastating immune mediated adverse drug reaction caused by the emergence of antibodies that activate platelets in the presence of heparin. Despite thrombocytopenia, bleeding is rare; rather, HIT is strongly associated with thromboembolic complications involving both the arterial and venous systems. A number of laboratory tests are available to confirm the diagnosis; however, when HIT is clinically suspected, treatment should not be withheld pending the result. Fortunately, therapeutic strategies have been refined, and new and effective therapeutic agents are available. Treatment options are focused on inhibiting thrombin formation or direct thrombin inhibition. Warfarin should not be used until the platelet count has recovered.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2600013Documentos Relacionados
- Heparin induced thrombocytopenia: clinical and laboratory aspects
- Laboratory Diagnosis of Heparin-Induced Thrombocytopenia and Monitoring of Alternative Anticoagulants
- Cyclic thrombocytopenia: A thrombopoietin deficiency?
- Dialysis-related thrombocytopenia: a case report
- Pathology—Important Advances in Clinical Medicine: Heparin-Induced Thrombocytopenia and Thrombosis